Vitamin K2 (Menaquinone-7)

1. Ingredient Overview

1. Common name and identity: Menaquinone-7 (MK-7), a long-chain Vitamin K2 form
2. Ingredient category: Fat-soluble menaquinone
3. Natural or commercial origin: Commonly fermentation-derived or synthetic; all-trans content and source require verification

Plain-language summary: Vitamin K2 (Menaquinone-7) may be supplied as oil, crystals, microencapsulated powder, or diluted premix with declared all-trans mk-7. Commercial materials can differ in chemical form, activity units, carriers, overage, particle size, dispersibility, and stability. The ingredient name alone is not enough for formulation or label calculations.

Why Vitamin K2 (Menaquinone-7) Matters
Ingredient identity, source, grade, concentration basis, documentation, and finished-product behavior must be qualified together. A familiar INCI name alone does not establish equivalence or quality.

2. Functional Benefits

1. Primary functions: Support the ingredient's established cosmetic role in a safe, stable, and appropriately positioned finished product
2. Secondary functions: Improve sensory, structure, delivery, conditioning, protection, or processing where the exact grade and formula support the outcome
3. Cosmetic functions: Vitamin k nutrition and activation of vitamin k-dependent proteins; supplement use requires interaction-aware positioning
4. Mechanism-based benefits: Its established roles include Vitamin K nutrition and activation of Vitamin K-dependent proteins; supplement use requires interaction-aware positioning. Nutritional function does not automatically support disease-treatment, energy, beauty, cardiovascular, cognitive, or anti-aging claims in a finished product.

3. Mechanism of Action and Chemistry

Chemical Classification

Menaquinone-7 (MK-7), a long-chain Vitamin K2 form belongs to the fat-soluble menaquinone family. Different salts, esters, stereoisomers, vitamers, and carriers can have different molecular weights, activity conversions, solubility, stability, and regulatory treatment.

Skin, Hair, or Formula Interaction

Performance depends on the exact grade, concentration, vehicle, co-ingredients, application area, use pattern, package, and target consumer. Ingredient-level rationale should not be presented as proof of a finished-product outcome.

Stability Considerations

Stability Profile
Control heat, light, oxygen, moisture, metals, contamination, physical state, compatible processing, storage, and packaging as relevant to the exact ingredient and complete formula.

4. Source and Raw Material Origin

1. Raw material source: Commercial origin is commonly: Commonly fermentation-derived or synthetic; all-trans content and source require verification. Supplier approval should identify feedstocks, fermentation organism where relevant, legal manufacturer, production and finishing sites, carriers, antioxidants, processing aids, countries of origin, and evidence supporting natural, vegan, fermentation-derived, or non-GMO claims.
2. Geographic origin: Document feedstock or raw-material origin, intermediate processors, manufacturing and refining sites, finishing or blending sites, distributor chain, and final packaging location.
3. Manufacturing pathway: Feedstock preparation → conversion, extraction, polymerization, refining, or fractionation → purification and finishing → testing → controlled packaging.
4. Renewability: Evaluate feedstocks, land or mineral use where relevant, water, energy, solvents or reagents, emissions, waste, transport, certification scope, and chain of custody. Origin alone does not prove sustainability.

Sourcing Transparency
Approve the exact identity, legal manufacturer, production sites, complete composition, source chain, processing method, and change-notification terms—not only a distributor's product name.

5. Manufacturing and Processing

1. Production method: Production and finishing are form-specific and may involve synthesis or fermentation, purification, crystallization, esterification or salt formation, drying, milling, dilution, beadleting, or microencapsulation. Release controls should cover identity, all-trans assay, cis isomers, carrier, residual solvents, oxidation products, water, microbiology, and stability potency.
2. Standardization: Confirm identity, composition or assay basis, physical properties, impurities, contaminants, microbiology where relevant, and stability requirements.
3. Quality control: Identity / purity / composition / physical properties / contaminants / residual materials / microbiology where relevant / sensory quality / stability
4. Consistency considerations: Feedstock, route, process controls, purification, finishing, physical form, packaging, transport, and storage can change lot performance.

Quality Control Steps

• Confirm identity with methods capable of distinguishing the claimed grade, composition, source, or material family.
• Reconcile the specification, certificate of analysis, test methods, lot, legal manufacturer, site, and expiry or retest date.
• Review impurities, contaminants, adulterants, residual processing materials, and microbiology using a source- and process-specific risk assessment.
• Verify physical and sensory properties on the same basis used for formulation, manufacturing, and claims.
• Require stability, storage, transport, opened-container, change-notification, complaint, recall, and continuity information.

6. Safety, Toxicology, and Regulatory Status

Cosmetic Regulatory Status

Vitamin K can interact seriously with warfarin and similar anticoagulants. MK-7 evidence and permitted uses must be reviewed for the target market, dose, population, and product category. Confirm current maximums, warnings, interactions, intended population, serving size, exposure, labeling, and claim rules for each target market.

In the United States, cosmetics must be safe under labeled or customary conditions of use and properly labeled. Drug claims or use as an OTC active require the applicable drug pathway. In the European Union, assess the complete formula under current cosmetics and, where relevant, REACH requirements.

Before launch, confirm ingredient status, concentration, exposure, claims, warnings, labeling, safety assessment, and regulatory requirements for each target market.

Safety Profile

• Evaluate safety for the exact grade, concentration, exposure area, use pattern, population, and complete formula.
• Review impurities, contaminants, allergens, inhalation or mucosal exposure, interactions, and vulnerable users where relevant.
• Avoid disease-treatment claims, absolute promises, and conclusions that exceed the supporting evidence.
• Maintain lot traceability, complaint handling, adverse-event procedures, and current market-specific regulatory documentation.

Regulatory Compliance Considerations
Ingredient permission, concentration, exposure, claims, labeling, purity, and manufacturing controls must be reviewed together for each target market.

7. Clinical Studies and Scientific Evidence

Evidence Summary

Authoritative nutrient guidance establishes biological function, but finished-product claims require evidence matching the exact form, dose, population, duration, matrix, comparator, and endpoint. Deficiency treatment and disease-risk claims follow different regulatory pathways from general wellness claims.

Study Types and Endpoints

• Analytical and laboratory studies: Identity, composition, stability, compatibility, physical behavior, and plausible cosmetic function
• Human cosmetic studies: Hydration, softness, smoothness, barrier-related measures, sensory, tolerability, hair performance, or color-cosmetic endpoints as relevant
• Finished-product studies: Exact grade, concentration, vehicle, application area, directions, target population, package, and shelf-life performance

Limitations

Published studies may use different grades, concentrations, vehicles, combinations, populations, endpoints, or supplier-funded materials. Results should not be transferred without confirming identity, composition, exposure, formula, and evidence relevance.

Clinical Evidence at a Glance
Claims should match the exact ingredient grade, concentration, finished formula, target population, study duration, application pattern, and measured endpoint.

8. Formulation and Application Guidance

Calculate from the exact form and as-supplied potency. Protect against known degradation pathways: sensitive to light, oxygen, heat, alkaline conditions, and incompatible mineral or premix environments; overage and packaging require evidence. Validate blend uniformity, dissolution or dispersion, sensory effects, assay, degradation products, package protection, and label potency through shelf life.

Typical Use Levels

Set the level from the exact grade, intended function, finished-product safety assessment, sensory target, processing behavior, evidence, and applicable market rules.

Compatibility

Compatibility is formula-specific. Evaluate polarity, solubility or dispersion, emulsifier and rheology systems, heat and shear, pH where relevant, preservation, oxidation, sensory, and package interactions.

Formulation Challenges and Solutions

Delivery Systems

1. Tablets and capsules: Control form, potency conversion, blend uniformity, compression, dissolution, and shelf-life assay.
2. Gummies, powders, and beverages: Validate solubility or dispersion, taste, color, processing loss, water activity, and package protection.
3. Oils, beadlets, and premixes: Confirm carrier, active basis, oxidation or light protection, release, and homogeneity.

Formulator's Note
Use the supplier's grade-specific process limits as a starting point, then verify identity, composition, appearance, sensory profile, physical stability, microbiology where relevant, preservative efficacy, package compatibility, and claims throughout finished-product shelf life.

9. Products and Applications

Common Product Types

Capsules, tablets, softgels, drops, powders, gummies, multinutrient products, and Vitamin D/calcium combinations.

Target Consumers

Brands developing supplements, fortified products, or selected topical formats where vitamin form, potency, stability, safety, and credible positioning must align.

Positioning

State MK-7 rather than generic K2, declare active all-trans content, and avoid guaranteed cardiovascular, bone-density, or clotting-treatment claims.

Real-World Product Examples
Select the format and level by ingredient behavior, target consumer, sensory expectations, manufacturing capability, safety assessment, claims, target market, and shelf-life requirements.

10. Supply Chain, Sustainability, and Quality Considerations

Supply Chain Characteristics

1. Supply risks: Key risks include wrong-form substitution, incorrect potency conversion, undisclosed carriers, inadequate overage rationale, oxidation or light loss, blend nonuniformity, assay drift, unsupported origin claims, and certificates that do not trace to the legal manufacturer.
2. Continuity: Review feedstock availability, manufacturing capacity, quality holds, logistics, regulatory transitions, and qualified backup options.
3. Lead times and price: Grade, purity, testing, documentation, packaging, order volume, certification, and regulatory support affect commercial terms.

Sustainability

• Request source- and site-specific information on feedstocks, water, energy, solvents or reagents, waste, emissions, and packaging.
• Verify environmental and social certifications, issuing bodies, validity, custody model, and exact facility and product scope.
• Do not treat plant, mineral, petroleum, synthetic, or silicone origin as automatic proof of environmental benefit or harm.

Adulteration and Quality Risks

1. Risk level: Higher when identity, composition, manufacturing site, source claims, or certificate traceability are unclear
2. Common issues: Substitution, dilution, undisclosed blends or carriers, incorrect assay or composition basis, contamination, specification drift, and unsupported origin or certification claims
3. Detection methods: Orthogonal identity and composition testing, impurity and contaminant review, physical and sensory checks, document reconciliation, retained-sample comparison, and lot traceability

Supplier Evaluation Checklist

• Exact identity, source, grade, composition, and functional basis
• Legal manufacturer, production and finishing sites, countries of origin, and distributor chain
• Current specification, methods, and representative certificates of analysis
• Impurity, contaminant, adulteration, allergen, residual-material, and microbiological controls where relevant
• Stability, storage, transport, shelf-life, packaging, and opened-container requirements
• Evidence matching the exact grade, concentration, target use, and proposed claims
• Regulatory, sustainability, origin, certification, and social-impact documentation covering the exact supply chain
• Change notification, complaint handling, recall readiness, audit status, and business continuity

Quality Markers

• Confirmed identity, source, legal manufacturer, production site, grade, lot, and document traceability
• Composition or functional property tested on the same basis used in formulation and supplier approval
• Controlled impurities, contaminants, adulterants, residual processing materials, and microbiology where relevant
• Consistent physical, sensory, and processing performance
• Finished-product stability in the intended packaging and distribution pathway
• Change-notification, complaint, recall, and business-continuity controls

11. How Does Vitamin K2 (Menaquinone-7) Compare to Related Ingredients?

Selection Considerations
Choose the grade by target consumer, intended cosmetic function, sensory needs, safety, regulatory path, analytical capability, source evidence, manufacturing requirements, and supply continuity—not by marketing familiarity alone.

‍